Browsing by Author Nada Alaa El-Deen

Showing results 1 to 1 of 1
Issue DateTitleAuthor(s)
2023AML and FLT3: An update on FDA-approved or under review kinase inhibitors targeting FLT3 kinaseNada Alaa El-Deen; Mai Jaballah; Abouzid, Khaled ; Dokla, Eman ; Serya, Rabah